이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)

2022년 4월 8일 업데이트: Sonova AG
This study will evaluate the clinical benefit of a transmitter for contralateral routing of signals. The benefit will be evaluated in noisy environments regarding speech intelligibility when the CROS system is adjusted to different microphone settings. Additionally, data regarding overall system stability, crash reboot rate, sound quality and connectivity will be obtained over a period of time to validate the CROS system in combination with smartphone and accessories. This study is a confirmatory study.

연구 개요

상세 설명

Unilateral Hearing Loss (UHL) can be defined as any degree of permanent hearing loss on one ear with normal hearing in the opposite ear. Unilateral hearing loss can be debilitating associated with audiological, psychosocial and educational challenges. Audiological challenges include the reduced ability to localize sounds, reduced awareness on the unaidable side and difficulties hearing in noise or at a distance.

One solution for unaidable UHL is Contralateral Routing of Signals (CROS) and Bilateral Contralateral routing of signals (BiCROS) using a so- called CROS transmitter together with a hearing aid.

The rationale for this clinical investigation is to collect clinical data with a rechargeable CROS transmitter to evaluate the benefits of a BiCROS fitting compared to the alternative treatment option, the monaural hearing aid fitting, and to no treatment in noisy listening situations.

연구 유형

중재적

등록 (실제)

23

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Zürich
      • Stäfa, Zürich, 스위스, 8712
        • Sonova AG

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • hearing impaired adults, with & w/o hearing aids (experiences)
  • good written and spoken (Swiss) German language skills
  • ability to fill in a questionnaire conscientiously
  • informed consent as documented by signature
  • asymmetric hearing loss: one unaidable ear (min. N6 hearing loss) / the other ear with N3 or N4 hearing loss
  • availability of Smartphone
  • availability of TV or Tablet
  • ability to operate and handle the investigational device
  • ability to describe listening impressions/experiences and the use of the hearing aid
  • Ability to produce a reliable hearing test result

Exclusion Criteria:

  • Contraindications to the medical device:
  • aidable hearing loss on the intended CROS side
  • acute tinnitus (in either one ear and occurrence less than three months)
  • anatomical deformity of the CROS ear (e.g. absence of the auricle)
  • Known hypersensitivity or allergy to materials of the investigational device
  • any auricle deformities, that prevents secure placement of the (test) devices
  • no willingness to test the investigational device system
  • no willingness to test the investigational device system for at least 8h a day
  • Hint for psychological problems from investigators point of view
  • reported fluctuating hearing that could influence the test result
  • reported symptoms of vertigo and dizziness by participants

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Speech Intelligibility with CROS device

The focus of this study is on Speech Intelligibility (SI), evaluated by the Oldenburg Sentence test (OLSA), which measures a speech recognition threshold (SRT) in dB SNR (signal to noise ratio).

Therefore each participant will perform the tests with the experimental rechargeable CROS transmitter (CROS) in different interventions, like comparison to monaural fitting and unaided condition.

All participants will perform the same tests. The order of the intervention in the speech test is randomized, but will be performed in the same visit by each participant.

치료 없음, 즉 참가자에게 CROS 장치 및/또는 보청기가 장착되어 있지 않습니다.

비보조 상태는 제어 개입으로 작동합니다.

Each participant will be fitted with the experimental CROS device on the poorer, unaidable ear and with a compatible hearing device on the other ear.

Each participant will be fitted with a hearing aid on the better hearing ear and no device on the poorer, unaidable ear.

Monaural hearing aid fitting acts as control intervention.

Each participant will be fitted with the experimental CROS device on the poorer, unaidable ear and with a compatible device on the other ear. The difference to the BiCROS condition is the setup of the microphones in the CROS device and the compatible hearing device.

This test condition is only tested for speech intelligibility in diffuse noise and acts as control intervention.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Speech Intelligibility (SI) in noise (fix direction): BiCROS fitting vs. monaural hearing aid fitting
기간: 2 weeks

The primary objective of this clinical investigation is to evaluate whether a BiCROS fitting (better ear fitted with a hearing device, unaidable ear supplied with a CROS device) improves speech intelligibility in noise compared to a monaural fitting (just the aidable ear is supplied by a hearing aid), for adults with an asymmetric hearing loss, measured with the Oldenburg Sentence Test (OLSA). Results of the speech test will be the SRT (speech recognition threshold) in dB SNR (signal to noise ratio).

The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
SI in noise (fix direction): BiCROS fitting vs. unaided
기간: 2 week

A secondary objective of this clinical investigation is to evaluate whether a BiCROS fitting improves speech intelligibility in noise compared to an unaided condition, for adults with an asymmetric hearing loss, measured with the Oldenburg Sentence Test (OLSA).

Results of the speech test will be the SRT (dB SNR). The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 week
SI in diffuse noise: BiCROS fitting vs. monaural fitting
기간: 2 weeks

A secondary objective of this clinical investigation is to evaluate whether a BiCROS fitting improves speech intelligibility by at least 1 dB SNR for 50% SRT in diffuse noise, compared to a monaural hearing aid fitting.

The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks
SI in diffuse noise: BiCROS fitting vs. unaided
기간: 2 weeks

A secondary objective of this clinical investigation is to evaluate whether a BiCROS fitting improves speech intelligibility by at least 1 dB SNR for 50% SRT in diffuse noise, compared to an unaided condition.

The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks
SI in diffuse noise: BiCROS vs. CROS baseline fitting
기간: 2 weeks

A secondary objective of this clinical investigation is to evaluate whether a BiCROS fitting improves speech intelligibility in diffuse noise compared with a CROS baseline fitting. CROS baseline means a fitting of an additional program with different hearing instrument microphone setup.

The SI will be tested with the OLSA in diffuse noise. The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks
SI in diffuse noise: CROS baseline fitting vs. unaided
기간: 2 weeks

A secondary objective of this clinical investigation is to evaluate whether a CROS baseline fitting improves speech intelligibility in diffuse noise compared with an unaided condition.

The SI will be tested with the OLSA in diffuse noise. The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks
SI in diffuse noise: CROS baseline fitting vs. monaural fitting
기간: 2 weeks

A secondary objective of this clinical investigation is to evaluate whether a CROS baseline fitting improves speech intelligibility in diffuse noise compared with a monaural fitting.

The SI will be tested with the OLSA in diffuse noise. The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks
SP in diffuse noise: monaural fitting vs. unaided
기간: 2 weeks

A secondary objective of this clinical investigation is to evaluate whether a monaural fitting improves speech intelligibility in diffuse noise compared with an unaided condition.

The SI will be tested with the OLSA in diffuse noise. The target speaker will be presented from 0° azimuth and is adaptive (start level at 65dB (A).

The noise will be presented on the better ear at an azimuth of 90° or 270° (depending on the site of the better ear), at a level of 70 dB (A).

2 weeks
Evaluation of Sound quality
기간: 3 weeks

A secondary objective of this study is to evaluate the participant's satisfaction of the sound quality of the experimental CROS device by a subjective rating during a three-week home trial period.

Scale: very unsatisfied- unsatisfied- neither nor- satisfied- very satisfied

3 weeks
Evaluation of System stability
기간: 3 weeks

A secondary objective of this study is to evaluate the participant's satisfaction of the system stability of the experimental CROS device during a three-week home trial period.

The participant shall report, if there are artefacts audible: never/ 1-2 times a week/ 3-6 times a week/ daily

3 weeks
Evaluation of streaming
기간: 3 weeks

A secondary objective of this study is to evaluate the participant's satisfaction of the streaming sound quality of the experimental CROS device, by a subjective rating during a three-week home trial period.

Scale: very unsatisfied- unsatisfied- neither nor- satisfied- very satisfied

3 weeks
Evaluation of listening effort
기간: 3 weeks

A secondary objective is to evaluate the subjective listening effort in noise reported by the participant whilst wearing the experimental CROS device.

Scale: not at all - slightly - somewhat - moderately - very - extremely

3 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2021년 10월 26일

기본 완료 (실제)

2022년 3월 14일

연구 완료 (실제)

2022년 3월 14일

연구 등록 날짜

최초 제출

2021년 10월 22일

QC 기준을 충족하는 최초 제출

2021년 10월 22일

처음 게시됨 (실제)

2021년 11월 3일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2022년 4월 15일

QC 기준을 충족하는 마지막 업데이트 제출

2022년 4월 8일

마지막으로 확인됨

2021년 11월 1일

추가 정보

이 연구와 관련된 용어

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다